2nd Closed Scientific Expert Meeting of the Editorial Board

Imaging of atherosclerotic vascular disease: The challenges and impact of therapy
Professor Raimund Erbel Director, Department of Cardiology, West German Heart Centre Essen
read more »
Very low LDL: Mechanism and potential clinical impact
Professor Eran Leitersdorf MD Professor of Medicine
read more »
PCSK9 Clinical trials: What’s new?
Dr Michel Farnier MD PhD Clinician based at Point Medical, Dijon, France
read more »
PCSK9: What do we still need to know about its biology and therapeutic applications
Dr Nabil Seidah PhD, OQ, MRSC, MC Director, Laboratory of Biochemical Neuroendocrinology
read more »
Genotypic and phenotypic variation in FH – relevance to cardiovascular risk
Professor Frederick Raal FRCP, FRCPC, FCP(SA), MMED, PhD Director, Carbohydrate & Lipid Metabolism Research Unit
read more »
Statin Intolerance: What is it? What are therapeutic options?
Professor Erik Stroes MD PhD Chairman, department of Vascular Medicine
read more »